These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 9618311

  • 1. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors.
    Ramsey WJ, Caplen NJ, Li Q, Higginbotham JN, Shah M, Blaese RM.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):912-9. PubMed ID: 9618311
    [Abstract] [Full Text] [Related]

  • 2. Adeno-retroviral chimeric viruses as in vivo transducing agents.
    Caplen NJ, Higginbotham JN, Scheel JR, Vahanian N, Yoshida Y, Hamada H, Blaese RM, Ramsey WJ.
    Gene Ther; 1999 Mar 29; 6(3):454-9. PubMed ID: 10435096
    [Abstract] [Full Text] [Related]

  • 3. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 29; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J, Kim SH, Kim JM, Yu SS, Robbins PD, Yim J, Kim S.
    Gene Ther; 1996 Sep 29; 3(9):780-8. PubMed ID: 8875226
    [Abstract] [Full Text] [Related]

  • 5. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
    Torrent C, Jullien C, Klatzmann D, Perricaudet M, Yeh P.
    Cancer Gene Ther; 2000 Aug 29; 7(8):1135-44. PubMed ID: 10975674
    [Abstract] [Full Text] [Related]

  • 6. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
    Xu L, Tsuji K, Mostowski H, Otsu M, Candotti F, Rosenberg AS.
    J Virol Methods; 2004 Jun 01; 118(1):61-7. PubMed ID: 15158069
    [Abstract] [Full Text] [Related]

  • 7. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
    Wildner O, Candotti F, Krecko EG, Xanthopoulos KG, Ramsey WJ, Blaese RM.
    Gene Ther; 1998 May 01; 5(5):684-91. PubMed ID: 9797874
    [Abstract] [Full Text] [Related]

  • 8. A defective retroviral vector encoding human interferon-alpha2 can transduce human leukemic cell lines.
    Austruy E, Bagnis C, Carbuccia N, Maroc C, Birg F, Dubreuil P, Mannoni P, Chabannon C.
    Cancer Gene Ther; 1998 May 01; 5(4):247-56. PubMed ID: 9694076
    [Abstract] [Full Text] [Related]

  • 9. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
    Tolmachov O.
    Med Hypotheses; 2006 May 01; 67(4):807-9. PubMed ID: 16759811
    [Abstract] [Full Text] [Related]

  • 10. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.
    Feng M, Jackson WH, Goldman CK, Rancourt C, Wang M, Dusing SK, Siegal G, Curiel DT.
    Nat Biotechnol; 1997 Sep 01; 15(9):866-70. PubMed ID: 9306401
    [Abstract] [Full Text] [Related]

  • 11. Detection of osteoclastic cell-cell fusion through retroviral vector packaging.
    Kondo T, Ikeda K, Matsuo K.
    Bone; 2004 Nov 01; 35(5):1120-6. PubMed ID: 15542037
    [Abstract] [Full Text] [Related]

  • 12. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
    Bauer G, Sauter S, Ibanez C, Rice CR, Valdez P, Jolly D, Kohn DB.
    Biol Blood Marrow Transplant; 1998 Nov 01; 4(3):119-27. PubMed ID: 9923409
    [Abstract] [Full Text] [Related]

  • 13. [Packaging and concentrating of high titer of retrovirus containing IL-4RA].
    Wang GL, Liu XT, Lu JR.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep 01; 11(9):761-4. PubMed ID: 19755029
    [Abstract] [Full Text] [Related]

  • 14. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
    Lin X.
    Gene Ther; 1998 Sep 01; 5(9):1251-8. PubMed ID: 9930327
    [Abstract] [Full Text] [Related]

  • 15. Generation of high-titer retroviral vectors following receptor-mediated, adenovirus-augmented transfection.
    von Rüden T, Stingl L, Cotten M, Wagner E, Zatloukal K.
    Biotechniques; 1995 Mar 01; 18(3):484-9. PubMed ID: 7779400
    [Abstract] [Full Text] [Related]

  • 16. Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates.
    Roberts ML, Athanasopoulos T, Pohlschmidt M, Duisit G, Cosset FL, Dickson G.
    Gene Ther; 2001 Oct 01; 8(20):1580-6. PubMed ID: 11704819
    [Abstract] [Full Text] [Related]

  • 17. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
    Sena-Esteves M, Hampl JA, Camp SM, Breakefield XO.
    J Gene Med; 2002 Oct 01; 4(3):229-39. PubMed ID: 12112640
    [Abstract] [Full Text] [Related]

  • 18. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
    Chen J, Reeves L, Sanburn N, Croop J, Williams DA, Cornetta K.
    Virology; 2001 Mar 30; 282(1):186-97. PubMed ID: 11259201
    [Abstract] [Full Text] [Related]

  • 19. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
    Fischer YH, Miletic H, Giroglou T, Litwak S, Stenzel W, Neumann H, von Laer D.
    J Gene Med; 2007 May 30; 9(5):335-44. PubMed ID: 17474071
    [Abstract] [Full Text] [Related]

  • 20. A novel human suspension culture packaging cell line for production of high-titre retroviral vectors.
    Chan LM, Coutelle C, Themis M.
    Gene Ther; 2001 May 30; 8(9):697-703. PubMed ID: 11406764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.